Clinical Trial Update: Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intravitreal injection of autologous bone marrow stem cells in patients with Retinitis Pigmentosa has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• Autologous bone marrow stem cell intravitreal injection (autologous bone marrow-derived stem cells for intravitreal use)

Snippet

Sponsor: Red de Terapia Celular | Conditions: Retinitis Pigmentosa | Phase 1 | Status: COMPLETED